(Q33984910)

30 July 2017

1 reference

title

Do atypical antipsychotics cause stroke? (English)

1 reference

30 July 2017

2

Krista L Lanctôt

1 reference

30 July 2017

Nathan Herrmann

1

1 reference

30 July 2017

publication date

1 January 2005

1 reference

30 July 2017

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

91-103

1 reference

Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioral symptoms associated with dementia

30 July 2017

cites work

1 reference

12 December 2020

Tying down the elderly. A review of the literature on physical restraint

1 reference

12 December 2020

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

12 December 2020

Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.

1 reference

12 December 2020

Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study

1 reference

12 December 2020

Evidence in upheaval: incorporating observational data into clinical practice

1 reference

12 December 2020

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

1 reference

12 December 2020

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

12 December 2020

Clozapine and venous thromboembolism

1 reference

12 December 2020

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease

1 reference

12 December 2020

Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century

1 reference

12 December 2020

Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease

1 reference

12 December 2020

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.

1 reference

12 December 2020

In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis

1 reference

12 December 2020

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials

1 reference

12 December 2020

Cerebral hypoperfusion induces cortical watershed microinfarcts which may further aggravate cognitive decline in Alzheimer's disease

1 reference

12 December 2020

Intra-individual postural blood pressure variability and stroke in elderly nursing home residents

1 reference

12 December 2020

Atypical antipsychotics and risk of cerebrovascular accidents.

1 reference

12 December 2020

The effects of antipsychotic drug treatment on prolactin concentrations in elderly patients

1 reference

12 December 2020

The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review.

1 reference

12 December 2020

The impact of dementia on the family

1 reference

12 December 2020

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents

1 reference

12 December 2020

The psychiatric symptoms of Alzheimer's disease.

1 reference

12 December 2020

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

12 December 2020

Mortality in elderly Canadians with and without dementia: a 5-year follow-up.

1 reference

12 December 2020

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

1 reference

12 December 2020

Association between risperidone treatment and cerebrovascular adverse events: examining the evidence and postulating hypotheses for an underlying mechanism

1 reference

12 December 2020

Randomized controlled trial of different models of care for nursing home residents with dementia complicated by depression or psychosis

1 reference

12 December 2020

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

1 reference

12 December 2020

Cognitive impairment and mortality in a cohort of elderly people

1 reference

12 December 2020

Behavioural management of aggression in dementia: a randomized controlled trial

1 reference

12 December 2020

Challenging behaviours in nursing home residents with dementia: a randomized controlled trial of multidisciplinary interventions.

1 reference

12 December 2020

PRL as a novel potent cofactor for platelet aggregation

1 reference

12 December 2020

A method for estimating the probability of adverse drug reactions

1 reference

12 December 2020

Recommendations for the management of behavioral and psychological symptoms of dementia.

1 reference

12 December 2020

The incremental direct costs associated with behavioral symptoms in AD.

1 reference

12 December 2020

Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

1 reference

12 December 2020

Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996

1 reference

12 December 2020

Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading

1 reference

12 December 2020

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

1 reference

12 December 2020

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

12 December 2020

Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women

1 reference

12 December 2020

Patient and caregiver characteristics and nursing home placement in patients with dementia

1 reference

12 December 2020

10.2165/00023210-200519020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1044707191

0 references

1 reference